Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: Q4QC64
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 3 |
GO:0016491 | oxidoreductase activity | 2 | 3 |
GO:0051213 | dioxygenase activity | 3 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 207 | 209 | PF00675 | 0.479 |
CLV_PCSK_KEX2_1 | 207 | 209 | PF00082 | 0.470 |
CLV_PCSK_SKI1_1 | 134 | 138 | PF00082 | 0.414 |
CLV_PCSK_SKI1_1 | 172 | 176 | PF00082 | 0.398 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.442 |
CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.634 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.590 |
DEG_SPOP_SBC_1 | 353 | 357 | PF00917 | 0.641 |
DOC_CKS1_1 | 188 | 193 | PF01111 | 0.399 |
DOC_MAPK_gen_1 | 169 | 178 | PF00069 | 0.392 |
DOC_PP2B_LxvP_1 | 109 | 112 | PF13499 | 0.588 |
DOC_PP2B_LxvP_1 | 151 | 154 | PF13499 | 0.423 |
DOC_PP4_FxxP_1 | 160 | 163 | PF00568 | 0.476 |
DOC_PP4_FxxP_1 | 37 | 40 | PF00568 | 0.530 |
DOC_USP7_MATH_1 | 100 | 104 | PF00917 | 0.441 |
DOC_USP7_MATH_1 | 154 | 158 | PF00917 | 0.489 |
DOC_USP7_MATH_1 | 353 | 357 | PF00917 | 0.641 |
DOC_WW_Pin1_4 | 181 | 186 | PF00397 | 0.394 |
DOC_WW_Pin1_4 | 187 | 192 | PF00397 | 0.383 |
DOC_WW_Pin1_4 | 231 | 236 | PF00397 | 0.596 |
LIG_14-3-3_CanoR_1 | 195 | 203 | PF00244 | 0.462 |
LIG_14-3-3_CanoR_1 | 207 | 211 | PF00244 | 0.335 |
LIG_BRCT_BRCA1_1 | 156 | 160 | PF00533 | 0.514 |
LIG_EH_1 | 254 | 258 | PF12763 | 0.381 |
LIG_FHA_1 | 115 | 121 | PF00498 | 0.507 |
LIG_FHA_1 | 146 | 152 | PF00498 | 0.491 |
LIG_FHA_1 | 16 | 22 | PF00498 | 0.473 |
LIG_FHA_1 | 188 | 194 | PF00498 | 0.398 |
LIG_FHA_1 | 23 | 29 | PF00498 | 0.506 |
LIG_FHA_2 | 347 | 353 | PF00498 | 0.708 |
LIG_FHA_2 | 79 | 85 | PF00498 | 0.478 |
LIG_Integrin_RGD_1 | 221 | 223 | PF01839 | 0.493 |
LIG_LIR_Apic_2 | 157 | 163 | PF02991 | 0.474 |
LIG_LIR_Apic_2 | 35 | 40 | PF02991 | 0.421 |
LIG_LIR_Gen_1 | 202 | 210 | PF02991 | 0.402 |
LIG_LIR_Gen_1 | 50 | 60 | PF02991 | 0.377 |
LIG_LIR_Nem_3 | 202 | 206 | PF02991 | 0.404 |
LIG_LIR_Nem_3 | 338 | 342 | PF02991 | 0.478 |
LIG_LIR_Nem_3 | 50 | 55 | PF02991 | 0.360 |
LIG_SH2_CRK | 203 | 207 | PF00017 | 0.396 |
LIG_SH2_SRC | 38 | 41 | PF00017 | 0.457 |
LIG_SH2_STAT3 | 273 | 276 | PF00017 | 0.444 |
LIG_SH2_STAT5 | 226 | 229 | PF00017 | 0.419 |
LIG_SH2_STAT5 | 273 | 276 | PF00017 | 0.359 |
LIG_SH2_STAT5 | 52 | 55 | PF00017 | 0.355 |
LIG_SH3_3 | 26 | 32 | PF00018 | 0.450 |
LIG_SH3_3 | 96 | 102 | PF00018 | 0.467 |
LIG_SUMO_SIM_anti_2 | 171 | 177 | PF11976 | 0.376 |
LIG_SUMO_SIM_par_1 | 190 | 197 | PF11976 | 0.500 |
LIG_WRC_WIRS_1 | 275 | 280 | PF05994 | 0.391 |
MOD_CDK_SPxxK_3 | 231 | 238 | PF00069 | 0.596 |
MOD_CK1_1 | 125 | 131 | PF00069 | 0.446 |
MOD_CK1_1 | 196 | 202 | PF00069 | 0.420 |
MOD_CK1_1 | 277 | 283 | PF00069 | 0.394 |
MOD_CK2_1 | 102 | 108 | PF00069 | 0.593 |
MOD_CK2_1 | 257 | 263 | PF00069 | 0.408 |
MOD_CK2_1 | 328 | 334 | PF00069 | 0.460 |
MOD_CK2_1 | 346 | 352 | PF00069 | 0.586 |
MOD_CK2_1 | 78 | 84 | PF00069 | 0.437 |
MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.633 |
MOD_GlcNHglycan | 124 | 127 | PF01048 | 0.417 |
MOD_GlcNHglycan | 259 | 262 | PF01048 | 0.479 |
MOD_GlcNHglycan | 309 | 312 | PF01048 | 0.585 |
MOD_GSK3_1 | 125 | 132 | PF00069 | 0.466 |
MOD_GSK3_1 | 141 | 148 | PF00069 | 0.326 |
MOD_GSK3_1 | 239 | 246 | PF00069 | 0.561 |
MOD_GSK3_1 | 267 | 274 | PF00069 | 0.446 |
MOD_N-GLC_1 | 280 | 285 | PF02516 | 0.385 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.461 |
MOD_NEK2_1 | 206 | 211 | PF00069 | 0.338 |
MOD_NEK2_1 | 257 | 262 | PF00069 | 0.392 |
MOD_NEK2_1 | 267 | 272 | PF00069 | 0.356 |
MOD_NEK2_1 | 55 | 60 | PF00069 | 0.507 |
MOD_PIKK_1 | 70 | 76 | PF00454 | 0.500 |
MOD_PK_1 | 161 | 167 | PF00069 | 0.371 |
MOD_PKA_2 | 168 | 174 | PF00069 | 0.404 |
MOD_PKA_2 | 194 | 200 | PF00069 | 0.441 |
MOD_PKA_2 | 206 | 212 | PF00069 | 0.345 |
MOD_Plk_4 | 125 | 131 | PF00069 | 0.445 |
MOD_Plk_4 | 161 | 167 | PF00069 | 0.387 |
MOD_Plk_4 | 246 | 252 | PF00069 | 0.573 |
MOD_Plk_4 | 268 | 274 | PF00069 | 0.358 |
MOD_Plk_4 | 323 | 329 | PF00069 | 0.532 |
MOD_ProDKin_1 | 181 | 187 | PF00069 | 0.401 |
MOD_ProDKin_1 | 231 | 237 | PF00069 | 0.593 |
MOD_SUMO_for_1 | 335 | 338 | PF00179 | 0.530 |
TRG_DiLeu_BaEn_1 | 263 | 268 | PF01217 | 0.464 |
TRG_DiLeu_BaLyEn_6 | 188 | 193 | PF01217 | 0.534 |
TRG_DiLeu_BaLyEn_6 | 26 | 31 | PF01217 | 0.380 |
TRG_ENDOCYTIC_2 | 203 | 206 | PF00928 | 0.396 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.355 |
TRG_ER_diArg_1 | 206 | 208 | PF00400 | 0.462 |
TRG_Pf-PMV_PEXEL_1 | 330 | 334 | PF00026 | 0.550 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBK0 | Leptomonas seymouri | 82% | 99% |
A0A0S4JR98 | Bodo saltans | 51% | 100% |
A0A1X0NXW7 | Trypanosomatidae | 62% | 100% |
A0A3S7WWQ0 | Leishmania donovani | 96% | 100% |
A0A422NSQ3 | Trypanosoma rangeli | 60% | 100% |
A4HZC9 | Leishmania infantum | 95% | 100% |
D0A155 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 62% | 100% |
E9AIQ4 | Leishmania braziliensis | 88% | 100% |
E9AVB6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
V5BRD2 | Trypanosoma cruzi | 64% | 100% |